Tom Hulick sees Eli Lilly (LLY) leading the GLP-1 race and evolving healthcare race, noting the company's retatrutide drug as an example. He explains how the company's developments play into a larger economic story and the "MAHA movement." Tom White offers an example options trade for Eli Lilly.